COVID-19: MSN Laboratories initiates Phase III clinical trial of Molnupiravir Nation COVID-19: MSN Laboratories initiates Phase III clinical trial of Molnupiravir News Analysis India 3 years ago By ANI NEW DELHI: MSN Laboratories Private Limited (MSN) is initiating phase III clinical trial of Molnupiravir capsules for the treatment of COVID-19 in...Read More